In the phase 2 trial, efficacy was also seen in patients with non-atopic chronic hand eczema treated with the oral JAK inhibitor.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/abrocitinib-effective-chronic-hand-eczema-phase-2-study-2026a1000acy?src=rss
Author :
Publish date : 2026-04-06 09:57:00
Copyright for syndicated content belongs to the linked Source.
